LIQUIDIA_Logo.jpg
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 11, 2020 16:01 ET | Liquidia Technologies, Inc.
Received FDA Acceptance of LIQ861 NDA for ReviewReported Final Safety and Tolerability Results for LIQ861 Inspire TrialManagement to Host Webcast and Conference Call Today at 4:30p.m. ET ...
NOVARTIS logo.jpg
Novartis receives CHMP positive opinion for Enerzair® Breezhaler® (QVM149), a potential first-in-class inhaled LABA/LAMA/ICS combination for uncontrolled asthma
May 01, 2020 01:15 ET | Novartis International AG
CHMP positive opinion advances efforts to provide first-in-class LABA/LAMA/ICS combination for patients whose asthma is uncontrolled with LABA/ICS standard-of-care treatment in the EU.  Digital...
Logo-Long.png
Circadia Health Commits $3 million in Respiratory Monitors to Global COVID-19 Efforts
April 02, 2020 06:47 ET | Circadia Health
LONDON, April 02, 2020 (GLOBE NEWSWIRE) -- Circadia Health announces $3 million in medical devices and services towards COVID-19 relief efforts across the globe. The company has expedited the...
Humidity helps in the fight against COVID-19, virologists report
March 13, 2020 13:32 ET | Dan Hess Research
Washington, D.C., March 13, 2020 (GLOBE NEWSWIRE) -- What can the public do to defend against the COVID-19 coronavirus?  One simple answer is to ramp up humidification at home and in the workplace,...
NOVARTIS logo.jpg
Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
December 16, 2019 01:15 ET | Novartis International AG
Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication Fevipiprant was well tolerated with adverse events balanced across treatment...
Reports and Data.jpeg-01
Immunomodulators Market To Reach USD 239.7 Billion By 2026 | Reports And Data
November 13, 2019 14:55 ET | Reports and Data
New York, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Production of advanced drugs, increasing adoption of monoclonal antibodies, and clinical urgency to develop new generation immunomodulators are key...
CleanSpace Logo.jpg
Cleanspace Launches Halo – a Revolutionary Respirator for the Healthcare Sector
June 10, 2019 07:00 ET | CleanSpace Technology
CHICAGO, June 10, 2019 (GLOBE NEWSWIRE) -- CleanSpace Technology, a global manufacturer of next generation respiratory protection equipment, today announced CleanSpace HALO is now available in North...
Earth Science Tech,
Earth Science Tech, Inc. Announces Partnership with Bionatus to Help Manufacture, Distribute, & Continue Further R&D on Cannabis (CBD) Products
August 22, 2017 08:25 ET | Earth Science Tech, Inc.
Hollywood, FL, Aug. 22, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid...
Parion Corporate Logo-01.png
Parion Sciences Announces Presentation of Clinical Data with Novel Pulmonary Delivery Device at the 2016 North American Cystic Fibrosis Conference
October 25, 2016 08:14 ET | Parion Sciences
DURHAM, N.C., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced that an abstract from its...
University of Colorado Hospital mtns smaller
U.S. News and World Report Names University of Colorado Hospital to Best Hospitals Honor Roll
August 02, 2016 00:51 ET | UCHealth
AURORA, Colo., Aug. 2, 2016 (GLOBE NEWSWIRE) -- For the first time, U.S. News and World Reporthas named University of Colorado Hospital (UCH) to the Best Hospitals Honor Roll, recognizing it as one of...